Amgen Revenue 2010-2024 | AMGN

Amgen annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Amgen revenue for the quarter ending December 31, 2024 was $9.086B, a 10.86% increase year-over-year.
  • Amgen revenue for the twelve months ending December 31, 2024 was $33.424B, a 18.57% increase year-over-year.
  • Amgen annual revenue for 2024 was $33.424B, a 18.57% increase from 2023.
  • Amgen annual revenue for 2023 was $28.19B, a 7.09% increase from 2022.
  • Amgen annual revenue for 2022 was $26.323B, a 1.32% increase from 2021.
Amgen Annual Revenue
(Millions of US $)
2024 $33,424
2023 $28,190
2022 $26,323
2021 $25,979
2020 $25,424
2019 $23,362
2018 $23,747
2017 $22,849
2016 $22,991
2015 $21,662
2014 $20,063
2013 $18,676
2012 $17,265
2011 $15,582
2010 $15,053
2009 $14,642
Amgen Quarterly Revenue
(Millions of US $)
2024-12-31 $9,086
2024-09-30 $8,503
2024-06-30 $8,388
2024-03-31 $7,447
2023-12-31 $8,196
2023-09-30 $6,903
2023-06-30 $6,986
2023-03-31 $6,105
2022-12-31 $6,839
2022-09-30 $6,652
2022-06-30 $6,594
2022-03-31 $6,238
2021-12-31 $6,846
2021-09-30 $6,706
2021-06-30 $6,526
2021-03-31 $5,901
2020-12-31 $6,634
2020-09-30 $6,423
2020-06-30 $6,206
2020-03-31 $6,161
2019-12-31 $6,197
2019-09-30 $5,737
2019-06-30 $5,871
2019-03-31 $5,557
2018-12-31 $6,230
2018-09-30 $5,904
2018-06-30 $6,059
2018-03-31 $5,554
2017-12-31 $5,802
2017-09-30 $5,773
2017-06-30 $5,810
2017-03-31 $5,464
2016-12-31 $5,965
2016-09-30 $5,811
2016-06-30 $5,688
2016-03-31 $5,527
2015-12-31 $5,536
2015-09-30 $5,723
2015-06-30 $5,370
2015-03-31 $5,033
2014-12-31 $5,331
2014-09-30 $5,031
2014-06-30 $5,180
2014-03-31 $4,521
2013-12-31 $5,011
2013-09-30 $4,748
2013-06-30 $4,679
2013-03-31 $4,238
2012-12-31 $4,421
2012-09-30 $4,319
2012-06-30 $4,477
2012-03-31 $4,048
2011-12-31 $3,973
2011-09-30 $3,944
2011-06-30 $3,959
2011-03-31 $3,706
2010-12-31 $3,841
2010-09-30 $3,816
2010-06-30 $3,804
2010-03-31 $3,592
2009-12-31 $3,809
2009-09-30 $3,812
2009-06-30 $3,713
2009-03-31 $3,308
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $152.575B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $218.669B 16.32
Gilead Sciences (GILD) US $128.563B 13.34
Vertex Pharmaceuticals (VRTX) US $128.247B 0.00
Bristol Myers Squibb (BMY) US $100.960B 6.76
GSK (GSK) GB $79.950B 9.50
CSL (CSLLY) AU $77.958B 0.00
Regeneron Pharmaceuticals (REGN) US $64.502B 15.46
Argenex SE (ARGX) NL $39.072B 268.87
Alnylam Pharmaceuticals (ALNY) US $33.189B 0.00
BeiGene (ONC) KY $25.286B 0.00
BioNTech SE (BNTX) DE $24.580B 0.00
Biogen (BIIB) US $17.701B 7.64
Genmab (GNMSF) DK $13.552B 13.96
Genmab (GMAB) DK $13.420B 16.88
Insmed (INSM) US $13.207B 0.00
Illumina (ILMN) US $12.109B 31.23
Incyte (INCY) US $12.007B 91.22
BioMarin Pharmaceutical (BMRN) US $11.965B 19.54
Swedish Orphan Biovitrum (BIOVF) SE $10.913B 27.87
Exelixis (EXEL) US $10.717B 22.22
Moderna (MRNA) US $10.450B 0.00
Ascendis Pharma (ASND) DK $10.211B 0.00
QIAGEN (QGEN) NL $9.381B 18.88
Exact Sciences (EXAS) US $8.894B 0.00
Roivant Sciences (ROIV) GB $8.263B 0.00
Bio-Techne Corp (TECH) US $7.846B 30.08
Repligen (RGEN) US $7.704B 86.29
Revolution Medicines (RVMD) US $7.570B 0.00
Halozyme Therapeutics (HALO) US $7.416B 15.31
Jazz Pharmaceuticals (JAZZ) IE $7.222B 6.43
TG Therapeutics (TGTX) US $7.204B 324.07
Bio-Rad Laboratories (BIO.B) US $6.566B 22.20
Blueprint Medicines (BPMC) US $6.343B 0.00
Legend Biotech (LEGN) US $6.237B 0.00
Sarepta Therapeutics (SRPT) US $6.169B 28.67
Verona Pharma American Depositary Share (VRNA) GB $6.141B 0.00
Telix Pharmaceuticals (TLX) AU $6.062B 0.00
Guardant Health (GH) US $6.054B 0.00
ADMA Biologics Inc (ADMA) US $5.529B 46.54
Axsome Therapeutics (AXSM) US $5.524B 0.00
Nuvalent (NUVL) US $5.458B 0.00
Cytokinetics (CYTK) US $5.116B 0.00
Alkermes (ALKS) IE $5.041B 13.53
Zealand Pharma (ZLDPF) DK $4.995B 0.00
Krystal Biotech (KRYS) US $4.788B 49.91
Vaxcyte (PCVX) US $4.546B 0.00
Rhythm Pharmaceuticals (RYTM) US $4.058B 0.00
Avidity Biosciences (RNA) US $3.940B 0.00
PTC Therapeutics (PTCT) US $3.924B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.659B 0.00
Akero Therapeutics (AKRO) US $3.610B 0.00
Arcellx (ACLX) US $3.609B 0.00
SpringWorks Therapeutics (SWTX) US $3.465B 0.00
Zai Lab (ZLAB) CN $3.431B 0.00
CRISPR Therapeutics AG (CRSP) CH $3.258B 0.00
Viking Therapeutics (VKTX) US $3.214B 0.00
Merus (MRUS) NL $3.144B 0.00
Scholar Rock Holding (SRRK) US $3.108B 0.00
Xenon Pharmaceuticals (XENE) CA $2.917B 0.00
Protagonist Therapeutics (PTGX) US $2.787B 10.71
Immunovant (IMVT) US $2.701B 0.00
MoonLake Immunotherapeutics (MLTX) CH $2.653B 0.00
HUTCHMED (China) (HCM) HK $2.580B 0.00
Apellis Pharmaceuticals (APLS) US $2.524B 0.00
Metsera (MTSR) US $2.454B 0.00
ACADIA Pharmaceuticals (ACAD) US $2.438B 21.75
Alvotech (ALVO) LU $2.394B 0.00
Denali Therapeutics (DNLI) US $2.333B 0.00
Biohaven (BHVN) US $2.291B 0.00
Kymera Therapeutics (KYMR) US $2.250B 0.00
Twist Bioscience (TWST) US $2.249B 0.00
ImmunityBio (IBRX) US $2.198B 0.00
Ascentage Pharma Group - (AAPG) CN $2.190B 0.00
Mirum Pharmaceuticals (MIRM) US $2.147B 0.00
Certara (CERT) US $2.146B 45.83
CG Oncology (CGON) US $2.114B 0.00
Tarsus Pharmaceuticals (TARS) US $2.113B 0.00
Ligand Pharmaceuticals (LGND) US $2.105B 0.00
Amicus Therapeutics (FOLD) US $2.057B 222.67
Kiniksa Pharmaceuticals (KNSA) GB $2.015B 0.00
NovoCure (NVCR) JE $2.001B 0.00
Beam Therapeutics (BEAM) US $1.994B 0.00
Belite Bio (BLTE) US $1.971B 0.00
Arrowhead Pharmaceuticals (ARWR) US $1.928B 0.00
Vericel (VCEL) US $1.901B 210.67
Janux Therapeutics (JANX) US $1.896B 0.00
Bavarian Nordic (BVNRY) DK $1.850B 13.03
Travere Therapeutics (TVTX) US $1.843B 0.00
IDEAYA Biosciences (IDYA) US $1.793B 0.00
Agios Pharmaceuticals (AGIO) US $1.792B 0.00
Apogee Therapeutics (APGE) US $1.759B 0.00
Edgewise Therapeutics (EWTX) US $1.748B 0.00
Arcutis Biotherapeutics (ARQT) US $1.746B 0.00
Disc Medicine (IRON) US $1.717B 0.00
Harmony Biosciences Holdings (HRMY) US $1.714B 11.90
Structure Therapeutics (GPCR) US $1.567B 0.00
ANI Pharmaceuticals (ANIP) US $1.539B 17.41
Mesoblast (MESO) AU $1.526B 0.00
Vera Therapeutics (VERA) US $1.514B 0.00
Immunocore Holdings (IMCR) GB $1.510B 0.00
MannKind (MNKD) US $1.504B 30.94
Dynavax Technologies (DVAX) US $1.405B 63.78
Celldex Therapeutics (CLDX) US $1.375B 0.00
Pacira BioSciences (PCRX) US $1.238B 11.63
WAVE Life Sciences (WVE) SG $1.223B 0.00
Liquidia Technologies (LQDA) US $1.195B 0.00
Syndax Pharmaceuticals (SNDX) US $1.189B 0.00
89BIO (ETNB) US $1.187B 0.00
GRAIL (GRAL) US $1.147B 0.00
Viridian Therapeutics (VRDN) US $1.121B 0.00
Adaptive Biotechnologies (ADPT) US $1.118B 0.00
Iovance Biotherapeutics (IOVA) US $1.112B 0.00
BGM Group (BGM) CN $1.099B 0.00
Novavax (NVAX) US $1.031B 0.00
Regencell Bioscience Holdings (RGC) HK $1.002B 0.00
Mineralys Therapeutics (MLYS) US $0.971B 0.00
NeoGenomics (NEO) US $0.934B 0.00
MiMedx (MDXG) US $0.933B 22.57
Pharvaris (PHVS) NL $0.933B 0.00
Arcus Biosciences (RCUS) US $0.913B 0.00
Geron (GERN) US $0.911B 0.00
Anbio Biotechnology (NNNN) DE $0.905B 0.00
Zymeworks (ZYME) US $0.896B 0.00
Intellia Therapeutics (NTLA) US $0.895B 0.00
Spyre Therapeutics (SYRE) US $0.884B 0.00
Gyre Therapeutics (GYRE) US $0.876B 116.75
Nurix Therapeutics (NRIX) US $0.851B 0.00
Vir Biotechnology (VIR) US $0.839B 0.00
Rocket Pharmaceuticals (RCKT) US $0.839B 0.00
UniQure (QURE) NL $0.822B 0.00
Bicara Therapeutics (BCAX) US $0.802B 0.00
LENZ Therapeutics (LENZ) US $0.795B 0.00
Anavex Life Sciences (AVXL) US $0.795B 0.00
Praxis Precision Medicines (PRAX) US $0.775B 0.00
Oculis Holding AG (OCS) CH $0.774B 0.00
Day One Biopharmaceuticals (DAWN) US $0.772B 0.00
Immunome (IMNM) US $0.771B 0.00
Nuvation Bio (NUVB) US $0.769B 0.00
CureVac (CVAC) DE $0.763B 4.15
AbCellera Biologics (ABCL) CA $0.743B 0.00
Replimune (REPL) US $0.742B 0.00
ArriVent BioPharma (AVBP) US $0.718B 0.00
Dianthus Therapeutics (DNTH) US $0.697B 0.00
Arbutus Biopharma (ABUS) US $0.691B 0.00
Trevi Therapeutics (TRVI) US $0.689B 0.00
Myriad Genetics (MYGN) US $0.657B 0.00
CorMedix Inc (CRMD) US $0.654B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
AnaptysBio (ANAB) US $0.642B 0.00
Cogent Biosciences (COGT) US $0.641B 0.00
Bicycle Therapeutics (BCYC) GB $0.628B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.626B 0.00
Pharming Group (PHGUF) NL $0.613B 0.00
Immatics (IMTX) DE $0.609B 35.79
Pharming Group (PHAR) NL $0.595B 0.00
Niagen Bioscience (NAGE) US $0.595B 189.00
Keros Therapeutics (KROS) US $0.592B 0.00
MeiraGTx Holdings (MGTX) US $0.580B 0.00
Sionna Therapeutics (SION) US $0.569B 0.00
GH Research (GHRS) IE $0.560B 0.00
Castle Biosciences (CSTL) US $0.557B 31.15
Tyra Biosciences (TYRA) US $0.556B 0.00
Fortrea Holdings (FTRE) US $0.550B 17.88
Stoke Therapeutics (STOK) US $0.539B 0.00
Arvinas (ARVN) US $0.528B 0.00
Urogen Pharma (URGN) US $0.526B 0.00
Opthea (OPT) AU $0.525B 0.00
Kura Oncology (KURA) US $0.524B 0.00
Cullinan Therapeutics (CGEM) US $0.503B 0.00
Mind Medicine (MindMed) (MNMD) US $0.497B 0.00
REGENXBIO (RGNX) US $0.493B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.492B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.491B 0.00
Zenas BioPharma (ZBIO) US $0.484B 0.00
Upstream Bio (UPB) US $0.483B 0.00
Cytek Biosciences (CTKB) US $0.472B 0.00
Prothena (PRTA) IE $0.469B 0.00
Sage Therapeutics (SAGE) US $0.468B 0.00
Maze Therapeutics (MAZE) US $0.464B 0.00
Precigen (PGEN) US $0.458B 0.00
Eton Pharmaceuticals (ETON) US $0.455B 0.00
Abivax SA (ABVX) FR $0.438B 0.00
Northwest Biotherapeutics (NWBO) US $0.433B 0.00
Sana Biotechnology (SANA) US $0.428B 0.00
PureTech Health (PRTC) US $0.424B 0.00
Erasca (ERAS) US $0.422B 0.00
Rapport Therapeutics (RAPP) US $0.419B 0.00
Oxford BioMedica (OXBDF) GB $0.419B 0.00
Mereo BioPharma Group - (MREO) GB $0.413B 0.00
Celcuity (CELC) US $0.409B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.404B 0.00
Oric Pharmaceuticals (ORIC) US $0.396B 0.00
Absci (ABSI) US $0.386B 0.00
Verastem (VSTM) US $0.383B 0.00
Kamada (KMDA) IL $0.378B 25.27
MBX Biosciences (MBX) US $0.377B 0.00
Allogene Therapeutics (ALLO) US $0.370B 0.00
Tectonic Therapeutic (TECX) US $0.367B 0.00
Olema Pharmaceuticals (OLMA) US $0.362B 0.00
Autolus Therapeutics (AUTL) GB $0.359B 0.00
Alpha Teknova (TKNO) US $0.353B 0.00
Checkpoint Therapeutics (CKPT) US $0.345B 0.00
Entrada Therapeutics (TRDA) US $0.343B 4.74
Arcturus Therapeutics Holdings (ARCT) US $0.339B 0.00
Benitec Biopharma (BNTC) US $0.338B 0.00
Abeona Therapeutics (ABEO) US $0.335B 0.00
Cartesian Therapeutics (RNAC) US $0.318B 0.00
Septerna (SEPN) US $0.318B 0.00
Terns Pharmaceuticals (TERN) US $0.311B 0.00
Aura Biosciences (AURA) US $0.305B 0.00
Monte Rosa Therapeutics (GLUE) US $0.301B 0.00
ATyr Pharma (ATYR) US $0.297B 0.00
MaxCyte (MXCT) US $0.297B 0.00
Astria Therapeutics (ATXS) US $0.291B 0.00
ITeos Therapeutics (ITOS) US $0.287B 0.00
Solid Biosciences (SLDB) US $0.283B 0.00
XOMA Royalty (XOMA) US $0.280B 0.00
Cidara Therapeutics (CDTX) US $0.273B 0.00
Design Therapeutics (DSGN) US $0.267B 0.00
Emergent Biosolutions (EBS) US $0.267B 0.00
Palvella Therapeutics (PVLA) US $0.266B 0.00
2seventy Bio (TSVT) US $0.265B 0.00
Monopar Therapeutics (MNPR) US $0.264B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.262B 0.00
Vanda Pharmaceuticals (VNDA) US $0.262B 0.00
ACELYRIN, INC (SLRN) US $0.260B 0.00
Atea Pharmaceuticals (AVIR) US $0.256B 0.00
Lifecore Biomedical (LFCR) US $0.253B 0.00
Compass Therapeutics (CMPX) US $0.252B 0.00
Aardvark Therapeutics (AARD) US $0.246B 0.00
Prima BioMed (IMMP) AU $0.244B 0.00
Candel Therapeutics (CADL) US $0.241B 0.00
Gossamer Bio (GOSS) US $0.241B 0.00
Corvus Pharmaceuticals (CRVS) US $0.240B 0.00
Rezolute (RZLT) US $0.240B 0.00
Kodiak Sciences (KOD) US $0.237B 0.00
Fulcrum Therapeutics (FULC) US $0.236B 0.00
DBV Technologies S.A (DBVT) FR $0.236B 0.00
Phathom Pharmaceuticals (PHAT) US $0.234B 0.00
BioStem Technologies (BSEM) $0.233B 9.31
Third Harmonic Bio (THRD) US $0.233B 0.00
Foghorn Therapeutics (FHTX) US $0.231B 0.00
Prime Medicine (PRME) US $0.228B 0.00
Amarin (AMRN) IE $0.227B 0.00
Nuvectis Pharma (NVCT) US $0.227B 0.00
Neurogene (NGNE) US $0.220B 0.00
Humacyte (HUMA) US $0.219B 0.00
Bright Minds Biosciences (DRUG) US $0.216B 0.00
Ocugen (OCGN) US $0.216B 0.00
Adocia (ADOCY) FR $0.213B 0.00
Anika Therapeutics (ANIK) US $0.207B 0.00
GENFIT S.A (GNFT) FR $0.204B 0.00
Annexon (ANNX) US $0.204B 0.00
CARGO Therapeutics (CRGX) US $0.202B 0.00
Eledon Pharmaceuticals (ELDN) US $0.196B 0.00
Voyager Therapeutics (VYGR) US $0.196B 0.00
Codexis (CDXS) US $0.192B 0.00
EnGene Holdings (ENGN) CA $0.191B 0.00
Y-mAbs Therapeutics (YMAB) US $0.186B 0.00
Innate Pharma S.A (IPHA) FR $0.186B 0.00
Actuate Therapeutics (ACTU) US $0.186B 0.00
Inventiva S.A (IVA) FR $0.184B 0.00
ProQR Therapeutics (PRQR) NL $0.181B 0.00
Alumis (ALMS) US $0.181B 0.00
Cardiff Oncology (CRDF) US $0.180B 0.00
Semper Paratus Acquisition (TVGN) US $0.180B 0.00
Inhibrx Biosciences (INBX) US $0.178B 0.00
DiaMedica Therapeutics (DMAC) US $0.177B 0.00
INmune Bio (INMB) US $0.174B 0.00
TuHURA Biosciences (HURA) US $0.170B 0.00
Sangamo Therapeutics (SGMO) US $0.170B 0.00
Adherex Technologies (FENC) US $0.169B 0.00
AC Immune (ACIU) CH $0.168B 0.00
Galena Biopharma (SLS) US $0.153B 0.00
Puma Biotechnology (PBYI) US $0.153B 5.05
Tango Therapeutics (TNGX) US $0.152B 0.00
Molecular Partners AG (MOLN) CH $0.151B 0.00
Tiziana Life Sciences (TLSA) GB $0.151B 0.00
BioAge Labs (BIOA) US $0.148B 0.00
Nkarta (NKTX) US $0.145B 0.00
Fate Therapeutics (FATE) US $0.142B 0.00
ADC Therapeutics SA (ADCT) CH $0.142B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.138B 0.00
Compugen (CGEN) IL $0.136B 0.00
Editas Medicine (EDIT) US $0.136B 0.00
Theratechnologies (THTX) CA $0.134B 0.00
Greenwich LifeSciences (GLSI) US $0.132B 0.00
ScPharmaceuticals (SCPH) US $0.127B 0.00
Vigil Neuroscience (VIGL) US $0.126B 0.00
Neumora Therapeutics (NMRA) US $0.125B 0.00
InflaRx (IFRX) DE $0.124B 0.00
Alector (ALEC) US $0.122B 0.00
Seer (SEER) US $0.122B 0.00
Coherus BioSciences (CHRS) US $0.122B 0.00
Rapt Therapeutics (RAPT) US $0.121B 0.00
Sagimet Biosciences (SGMT) US $0.121B 0.00
C4 Therapeutics (CCCC) US $0.116B 0.00
Immunic (IMUX) US $0.112B 0.00
BioHarvest Sciences (BHST) CA $0.109B 0.00
Orchestra BioMed Holdings (OBIO) US $0.105B 0.00
Coya Therapeutics (COYA) US $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.104B 0.00
Contineum Therapeutics (CTNM) US $0.103B 0.00
Entera Bio (ENTX) IL $0.101B 0.00
Zura Bio (ZURA) US $0.101B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.100B 0.00
Pliant Therapeutics (PLRX) US $0.099B 0.00
Ventyx Biosciences (VTYX) US $0.098B 0.00
HilleVax (HLVX) US $0.097B 0.00
Black Diamond Therapeutics (BDTX) US $0.096B 0.00
Kyverna Therapeutics (KYTX) US $0.096B 0.00
Alpha Cognition (ACOG) CA $0.096B 0.00
EXoZymes (EXOZ) US $0.092B 0.00
CervoMed (CRVO) US $0.092B 0.00
Genelux (GNLX) US $0.092B 0.00
Sutro Biopharma (STRO) US $0.090B 0.00
Elutia (ELUT) US $0.090B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.090B 0.00
Cellectis S.A (CLLS) FR $0.090B 0.00
XBiotech (XBIT) US $0.089B 0.00
TScan Therapeutics (TCRX) US $0.088B 0.00
Nautilus Biotechnology (NAUT) US $0.086B 0.00
Climb Bio (CLYM) US $0.085B 0.00
Senti Biosciences (SNTI) US $0.085B 0.00
Seres Therapeutics (MCRB) US $0.083B 0.00
Instil Bio (TIL) US $0.083B 0.00
Vor Biopharma (VOR) $0.083B 0.00
Jasper Therapeutics (JSPR) US $0.081B 0.00
IGM Biosciences (IGMS) US $0.080B 0.00
Elicio Therapeutics (ELTX) US $0.080B 0.00
Inozyme Pharma (INZY) US $0.078B 0.00
Biomea Fusion (BMEA) US $0.076B 0.00
Caribou Biosciences (CRBU) US $0.075B 0.00
Adagene (ADAG) CN $0.074B 0.00
Adlai Nortye (ANL) KY $0.074B 0.00
Invivyd (IVVD) US $0.073B 0.00
Genenta Science S.p.A (GNTA) IT $0.073B 0.00
BeyondSpring (BYSI) US $0.072B 0.00
MediciNova (MNOV) US $0.072B 0.00
I-Mab (IMAB) US $0.071B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.071B 0.00
Milestone Pharmaceuticals (MIST) CA $0.071B 0.00
Adverum Biotechnologies (ADVM) US $0.070B 0.00
Inovio Pharmaceuticals (INO) US $0.069B 0.00
ZIVO Bioscience (ZIVO) US $0.069B 0.00
VistaGen Therapeutics (VTGN) US $0.068B 0.00
IO Biotech (IOBT) DK $0.067B 0.00
Alto Neuroscience (ANRO) US $0.066B 0.00
Clearside Biomedical (CLSD) US $0.066B 0.00
VTv Therapeutics (VTVT) US $0.065B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
Prenetics Global (PRE) HK $0.064B 0.00
Citius Oncology (CTOR) US $0.064B 0.00
Cabaletta Bio (CABA) US $0.063B 0.00
Exicure (XCUR) US $0.063B 0.00
Skye Bioscience (SKYE) US $0.063B 0.00
Rani Therapeutics Holdings (RANI) US $0.062B 0.00
CytomX Therapeutics (CTMX) US $0.061B 1.99
Achilles Therapeutics (ACHL) GB $0.061B 0.00
PDS Biotechnology (PDSB) US $0.061B 0.00
Agenus (AGEN) US $0.061B 0.00
Repare Therapeutics (RPTX) CA $0.060B 0.00
Akoya Biosciences (AKYA) US $0.060B 0.00
Precision BioSciences (DTIL) US $0.060B 0.00
Ikena Oncology (IKNA) US $0.059B 0.00
Applied Therapeutics (APLT) US $0.059B 0.00
Medicus Pharma (MDCX) US $0.058B 0.00
Artiva Biotherapeutics (ARTV) US $0.058B 0.00
Immix Biopharma (IMMX) US $0.057B 0.00
Earth Science Tech (ETST) US $0.053B 0.00
OKYO Pharma (OKYO) $0.053B 0.00
Adicet Bio (ACET) US $0.052B 0.00
Fortress Biotech (FBIO) US $0.052B 0.00
Shattuck Labs (STTK) US $0.052B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.052B 0.00
Cyclacel Pharmaceuticals (CYCC) US $0.051B 0.00
Oncobiologics (OTLK) US $0.050B 0.00
Mersana Therapeutics (MRSN) US $0.050B 0.00
Renovaro (RENB) US $0.049B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.048B 0.00
PepGen (PEPG) US $0.048B 0.00
Quince Therapeutics (QNCX) US $0.048B 0.00
Oncolytics Biotech (ONCY) CA $0.048B 0.00
Forte Biosciences (FBRX) US $0.047B 0.00
Cue Biopharma (CUE) US $0.046B 0.00
Immuneering (IMRX) US $0.046B 0.00
Connect Biopharma Holdings (CNTB) US $0.045B 0.00
Atara Biotherapeutics (ATRA) US $0.045B 0.00
Tenaya Therapeutics (TNYA) US $0.045B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.044B 0.00
Kronos Bio (KRON) US $0.044B 0.00
Opus Genetics (IRD) US $0.043B 0.00
Advanced Biomed (ADVB) US $0.041B 0.00
Whitehawk Therapeutics (WHWK) US $0.041B 0.00
Estrella Immunopharma (ESLA) US $0.041B 0.00
Bluebird Bio (BLUE) US $0.040B 0.00
TELA Bio (TELA) US $0.040B 0.00
Xilio Therapeutics (XLO) US $0.039B 0.00
Werewolf Therapeutics (HOWL) US $0.039B 0.00
Lantern Pharma (LTRN) US $0.039B 0.00
FibroBiologics (FBLG) US $0.039B 0.00
Tvardi Therapeutics (TVRD) US $0.039B 0.00
CAMP4 Therapeutics (CAMP) US $0.038B 0.00
Celularity (CELU) US $0.037B 0.00
AN2 Therapeutics (ANTX) US $0.037B 0.00
Akari Therapeutics (AKTX) GB $0.037B 0.00
Aligos Therapeutics (ALGS) US $0.037B 0.00
Spero Therapeutics (SPRO) US $0.037B 0.00
Dyadic (DYAI) US $0.036B 0.00
RenovoRx (RNXT) US $0.036B 0.00
Rein Therapeutics (RNTX) US $0.036B 0.00
Boundless Bio (BOLD) US $0.036B 0.00
Scilex Holding (SCLX) US $0.035B 0.00
OnKure Therapeutics (OKUR) US $0.034B 0.00
Pluri (PLUR) IL $0.033B 0.00
LAVA Therapeutics (LVTX) NL $0.033B 0.00
Kezar Life Sciences (KZR) US $0.032B 0.00
Cadrenal Therapeutics (CVKD) US $0.032B 0.00
Femasys (FEMY) US $0.032B 0.00
Alterity Therapeutics - (ATHE) AU $0.031B 0.00
Radiopharm Theranostics - (RADX) AU $0.030B 0.00
Kalaris Therapeutics (KLRS) US $0.030B 0.00
Allakos (ALLK) US $0.029B 0.00
Generation Bio (GBIO) US $0.029B 0.00
MiNK Therapeutics (INKT) US $0.029B 0.00
BioAtla (BCAB) US $0.029B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.028B 0.00
Cognition Therapeutics (CGTX) US $0.028B 0.00
ALX Oncology Holdings (ALXO) US $0.028B 0.00
Grace Therapeutics (GRCE) CA $0.027B 0.00
Clene (CLNN) US $0.027B 0.00
Dare Bioscience (DARE) US $0.026B 0.00
CollPlant Biotechnologies (CLGN) IL $0.025B 0.00
KALA BIO (KALA) US $0.024B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Longeveron (LGVN) US $0.023B 0.00
Ovid Therapeutics (OVID) US $0.022B 0.00
Annovis Bio (ANVS) US $0.022B 0.00
X4 Pharmaceuticals (XFOR) US $0.022B 0.00
CalciMedica (CALC) US $0.022B 0.00
Lexaria Bioscience (LEXX) CA $0.022B 0.00
Promis Neurosciences (PMN) CA $0.021B 0.00
Curis (CRIS) US $0.021B 0.00
Passage Bio (PASG) US $0.021B 0.00
Lisata Therapeutics (LSTA) US $0.021B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.021B 0.00
Elevation Oncology (ELEV) US $0.020B 0.00
Allarity Therapeutics (ALLR) US $0.020B 0.00
Chemomab Therapeutics (CMMB) IL $0.020B 0.00
MIRA Pharmaceuticals (MIRA) US $0.019B 0.00
Q32 Bio (QTTB) US $0.019B 0.00
UNITY Biotechnology (UBX) US $0.019B 0.00
Beyond Air (XAIR) US $0.018B 0.00
Quantum Biopharma (QNTM) CA $0.018B 0.00
Affimed (AFMD) DE $0.018B 0.00
Aspire Biopharma Holdings (ASBP) US $0.018B 0.00
Gelteq (GELS) AU $0.018B 0.00
ABVC BioPharma (ABVC) US $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Cingulate (CING) US $0.017B 0.00
Edesa Biotech (EDSA) CA $0.017B 0.00
HOOKIPA Pharma (HOOK) US $0.016B 0.00
SAB Biotherapeutics (SABS) US $0.016B 0.00
BRIACELL THERAP (BCTX) CA $0.015B 0.00
Equillium (EQ) US $0.015B 0.00
BioCardia (BCDA) US $0.015B 0.00
NeuroSense Therapeutics (NRSN) IL $0.014B 0.00
Moleculin Biotech (MBRX) US $0.014B 0.00
IN8bio (INAB) US $0.014B 0.00
GeoVax Labs (GOVX) US $0.014B 0.00
Bolt Biotherapeutics (BOLT) US $0.013B 0.00
NextCure (NXTC) US $0.013B 0.00
Biorestorative Therapies (BRTX) US $0.013B 0.00
Synlogic (SYBX) US $0.013B 0.00
Rallybio (RLYB) US $0.013B 0.00
Bionano Genomics (BNGO) US $0.012B 0.00
Imunon (IMNN) US $0.012B 0.00
COSCIENS Biopharma (CSCI) CA $0.012B 0.00
Hoth Therapeutics (HOTH) US $0.012B 0.00
LakeShore Biopharma (LSB) CN $0.012B 0.00
Abpro Holdings (ABP) US $0.011B 0.00
Portage Biotech (PRTG) $0.011B 0.00
Athira Pharma (ATHA) US $0.011B 0.00
Cyclerion Therapeutics (CYCN) US $0.011B 0.00
IMMURON (IMRN) AU $0.011B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
IBio (IBIO) US $0.010B 0.00
Sensei Biotherapeutics (SNSE) US $0.010B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
BioXcel Therapeutics (BTAI) US $0.010B 0.00
Acurx Pharmaceuticals (ACXP) US $0.009B 0.00
Neuphoria Therapeutics (NEUP) AU $0.009B 0.00
Creative Medical Technology Holdings (CELZ) US $0.009B 0.00
HCW Biologics (HCWB) US $0.009B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.009B 0.00
BioAffinity Technologies (BIAF) US $0.009B 0.00
Intensity Therapeutics (INTS) US $0.009B 0.00
Aytu BioPharma (AYTU) US $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.008B 0.00
Apollomics (APLM) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.007B 0.00
180 Life Sciences (ATNF) US $0.007B 0.00
GENPREX (GNPX) US $0.007B 0.00
MetaVia (MTVA) US $0.007B 0.00
Biofrontera (BFRI) US $0.007B 0.00
Lipella Pharmaceuticals (LIPO) US $0.006B 0.00
GT Biopharma (GTBP) US $0.006B 0.00
Evogene (EVGN) IL $0.006B 0.00
Avalon GloboCare (ALBT) US $0.006B 0.00
Adial Pharmaceuticals (ADIL) US $0.005B 0.00
Onconetix (ONCO) US $0.005B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Arcadia Biosciences (RKDA) US $0.005B 0.00
Ensysce Biosciences (ENSC) US $0.005B 0.00
Soligenix (SNGX) US $0.005B 0.00
Alzamend Neuro (ALZN) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Pasithea Therapeutics (KTTA) US $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.004B 0.00
Novogen (KZIA) AU $0.004B 0.00
Sunshine Biopharma (SBFM) US $0.004B 0.00
Organovo Holdings (VIVS) US $0.004B 0.00
Mustang Bio (MBIO) US $0.004B 0.00
Windtree Therapeutics (WINT) US $0.004B 0.00
Titan Pharmaceuticals (TTNP) US $0.004B 0.00
Silo Pharma (SILO) US $0.004B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Tharimmune (THAR) US $0.003B 0.00
Synaptogenix (SNPX) US $0.003B 0.00
Artelo Biosciences (ARTL) US $0.003B 0.00
Eyenovia (EYEN) US $0.003B 0.00
Hepion Pharmaceuticals (HEPA) US $0.003B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
CNS Pharmaceuticals (CNSP) US $0.003B 0.00
NuCana (NCNA) GB $0.003B 0.00
Aptevo Therapeutics (APVO) US $0.003B 0.00
Revelation Biosciences (REVB) US $0.003B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
Evaxion Biotech (EVAX) DK $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Psyence Biomedical (PBM) CA $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
ZyVersa Therapeutics (ZVSA) US $0.002B 0.00
Polyrizon (PLRZ) IL $0.001B 0.00
GRI Bio (GRI) US $0.001B 0.00
Capstone Therapeutics (CAPS) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00